Insulin Degludec Provides Similar Glycemic Control with Insulin Glargine in Patients with Type 2 Diabetes

被引：0
|
作者：
Yamada, Satoru
Komuro, Manaho
Inoue, Gaku
Tabata, Mitsuhisa
Matsubara, Hajime
Irie, Junichiro
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
968-P
引用
收藏
页码：A250 / A251
页数：2
相关论文
共 50 条
  • [1] Comparison of Insulin Glargine with Insulin Degludec in Type 1 Diabetes Patients
    Kuroda, Akio
    Tsuruo, Miho
    Takeshi, Kondo
    Aki, Nanako
    Oguro, Yukari
    Endo, Itsuro
    Aihara, Ken-ichi
    Tamaki, Motoyuki
    Matsumoto, Toshio
    Matsuhisa, Munehide
    [J]. DIABETES, 2014, 63 : A232 - A232
  • [2] Type 2 Diabetes: Direct Comparison between Insulin Glargine and Insulin Degludec
    Lichert, Frank
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2018, 13 (06) : 546 - 546
  • [3] Insulin Degludec is Superior to Sitagliptin in Improving Glycemic Control in Insulin-Naive Patients With Type 2 Diabetes
    Philis-Tsimikas, Athena
    Del Prato, Stefano
    Satman, Ilhan
    Bhargava, Anuj
    Dharmalingam, Mala
    Skjoth, Trine V.
    Rasmussen, Soren
    Garber, Alan J.
    [J]. DIABETES, 2012, 61 : A263 - A263
  • [4] Insulin glulisine provides improved glycemic control in patients with type 2 diabetes
    Dailey, G
    Rosenstock, J
    Moses, RG
    Ways, K
    [J]. DIABETES CARE, 2004, 27 (10) : 2363 - 2368
  • [5] A pilot study comparing the CGM-assessed glycemic profiles of patients with type 1 diabetes on insulin degludec and insulin glargine
    Kuroda A.
    Tsuruo M.
    Aki N.
    Kondo T.
    Oguro Y.
    Tamaki M.
    Aihara K.-I.
    Endo I.
    Matsumoto T.
    Abe M.
    Matsuhisa M.
    [J]. Diabetology International, 2017, 8 (1) : 112 - 115
  • [6] Comparison of Insulin Detemir and Insulin Glargine on Glycemic Variability in Patients with Type 1 and Type 2 Diabetes
    Tone, A.
    Iseda, I.
    Higuchi, C.
    Tsukamoto, K.
    Katayama, A.
    Matsushita, Y.
    Hida, K.
    Wada, J.
    Shikata, K.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (05) : 320 - 324
  • [7] Similar glycemic profiles with dinner or bedtime insulin glargine in type 1 diabetes
    Vialettes, B
    Grimaldi, A
    Brun, JM
    Halimi, S
    Vaur, L
    Dubroca, I
    Blayo, A
    [J]. DIABETES, 2004, 53 : A150 - A150
  • [8] Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therapy in patients with type 2 diabetes uncontrolled with dual oral agent therapy
    Hollander, Priscilla
    Sugimoto, Danny
    Vlajnic, Aleksandra
    Kilo, Charles
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1266 - 1271
  • [9] Feasibility of improved glycemic control with insulin detemir and insulin glargine in combination with oral agents in insulin naive patients with type 2 diabetes
    Rosenstock, J
    Larsen, JJ
    Draeger, E
    Kristensen, HS
    Davies, M
    [J]. DIABETES, 2004, 53 : A145 - A145
  • [10] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 Diabetes
    Cheng, Huafeng
    Wan, Xu
    Ma, Jing
    Wu, Bin
    [J]. CLINICAL THERAPEUTICS, 2019, 41 (03) : 445 - 455
12345